| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Concurrent with our summer feature series on stem cell research, Drug Discovery News (ddn), in partnership with the healthcare research team at investment bankMizuho Securities USA, is conducting a reader survey on current stemcell trends and usage.

Whether you work at the bench or for anacademic institution—or anywhere in between
we are interested in finding out about your participation in and views on the stem cell market.

The survey contains 20 questions and takes four to fiveminutes to complete. To participate, please click on the link below:

http://www.surveymonkey.com/s/9HVX6V2

All information will remain confidential, and only aggregate results will be published.

If you are interested in receiving a copy of the survey results, please indicate at the end of the survey.

About the Author

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue